Lanzhou Foci Pharmaceutical Co Ltd
LanZhou Foci Pharmaceutical Co.,Ltd., research and development, production, and sales of traditional chinese medicines and health products in China. The company offers its products in various dosage forms, including pills, tablets, granules, capsules, and gelatin under the MingShan, BaoShu, BaoLu, and Foci brands. It also engages in planting and selling of Chinese medicinal materials; processing … Read more
Lanzhou Foci Pharmaceutical Co Ltd (002644) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.041x
Based on the latest financial reports, Lanzhou Foci Pharmaceutical Co Ltd (002644) has a cash flow conversion efficiency ratio of 0.041x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥75.62 Million) by net assets (CN¥1.85 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Lanzhou Foci Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2024)
This chart illustrates how Lanzhou Foci Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Lanzhou Foci Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Lanzhou Foci Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Integrated Service Technology
TWO:3289
|
0.038x |
|
Caisse Regionale de Credit Agricole Mutuel d’IlleetVilaine SC
PA:CIV
|
-0.106x |
|
Jiangsu Chunlan Refrigerating Equipment Stock Co Ltd
SHG:600854
|
0.006x |
|
CHINA YOUZAN LTD. HD-01
F:YSZ
|
N/A |
|
Hangzhou Biotest Biotech Co Ltd
SHG:688767
|
0.012x |
|
STI Co. Ltd
KQ:039440
|
-0.035x |
|
Berry Petroleum Corp
NASDAQ:BRY
|
0.087x |
|
Guangzheng Group Co Ltd
SHE:002524
|
0.188x |
Annual Cash Flow Conversion Efficiency for Lanzhou Foci Pharmaceutical Co Ltd (2007–2024)
The table below shows the annual cash flow conversion efficiency of Lanzhou Foci Pharmaceutical Co Ltd from 2007 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.81 Billion | CN¥38.98 Million | 0.021x | -42.20% |
| 2023-12-31 | CN¥1.77 Billion | CN¥65.71 Million | 0.037x | -10.97% |
| 2022-12-31 | CN¥1.73 Billion | CN¥72.37 Million | 0.042x | +472.99% |
| 2021-12-31 | CN¥1.63 Billion | CN¥11.85 Million | 0.007x | -81.62% |
| 2020-12-31 | CN¥1.59 Billion | CN¥62.89 Million | 0.040x | +24.86% |
| 2019-12-31 | CN¥1.51 Billion | CN¥47.82 Million | 0.032x | +24.68% |
| 2018-12-31 | CN¥1.44 Billion | CN¥36.66 Million | 0.025x | -47.92% |
| 2017-12-31 | CN¥1.36 Billion | CN¥66.42 Million | 0.049x | +10.85% |
| 2016-12-31 | CN¥1.29 Billion | CN¥56.90 Million | 0.044x | -15.17% |
| 2015-12-31 | CN¥1.23 Billion | CN¥64.11 Million | 0.052x | -59.24% |
| 2014-12-31 | CN¥735.22 Million | CN¥93.75 Million | 0.128x | +956.24% |
| 2013-12-31 | CN¥703.37 Million | CN¥-10.47 Million | -0.015x | +8.69% |
| 2012-12-31 | CN¥675.53 Million | CN¥-11.02 Million | -0.016x | -535.65% |
| 2011-12-31 | CN¥648.08 Million | CN¥2.43 Million | 0.004x | -97.82% |
| 2010-12-31 | CN¥326.46 Million | CN¥56.18 Million | 0.172x | +1156.35% |
| 2009-12-31 | CN¥252.96 Million | CN¥3.46 Million | 0.014x | +392.85% |
| 2008-12-31 | CN¥216.81 Million | CN¥602.56K | 0.003x | -99.49% |
| 2007-12-31 | CN¥195.20 Million | CN¥105.61 Million | 0.541x | -- |